<SEC-DOCUMENT>0001213900-17-005401.txt : 20170517
<SEC-HEADER>0001213900-17-005401.hdr.sgml : 20170517
<ACCEPTANCE-DATETIME>20170517091524
ACCESSION NUMBER:		0001213900-17-005401
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20170511
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170517
DATE AS OF CHANGE:		20170517

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-53605
		FILM NUMBER:		17850382

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k051117_optimizerxcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FORM 8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 13 OR 15(d) OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES EXCHANGE ACT OF 1934</B><BR>
<BR>
Date of Report (Date of earliest event reported): May 11, 2017<BR>
<BR>
<U>OptimizeRx Corporation</U><BR>
(Exact name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-decoration: none">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada</FONT></TD>
    <TD STYLE="width: 2%; text-decoration: none; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-53605</FONT></TD>
    <TD STYLE="width: 2%; text-decoration: none; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26-1265381</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of<BR>
incorporation)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    File Number)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer<BR>
Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 49%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400
    Water Street, Suite 200, Rochester, MI</FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 49%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48307</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: <U>248.651.6568</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 100%; padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;________________________________________________</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
        name or former address, if changed since last report)</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 4%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 96%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company&nbsp;&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
1 &ndash; <FONT STYLE="text-transform: uppercase">Registrant&rsquo;s Business and Operations</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 10%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                                         1.01</B></FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Entry
                                         into a Material Definitive Agreement </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 11, 2017, we entered into a Separation and Stock Purchase Agreement (the &ldquo;Agreement&rdquo;) with our director, Mr. David
Harrell, pursuant to which we agreed to repurchase from Mr. Harrell 500,000 shares of our common stock for aggregate consideration
of $390,000, representing a purchase price of $0.78 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
under the Agreement, we agreed that the consulting agreement with Mr. Harrell shall terminate on July 31, 2017, but that his non-compete
agreement with us shall extend to July 31, 2019. The Agreement also stipulates that Mr. Harrell shall resign as a member of our
board of directors effective June 30, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the complete
text of the Agreement filed as Exhibit 10.1 hereto, and incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5 &ndash; <FONT STYLE="text-transform: uppercase">Corporate Governance and Management</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 10%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                                         5.02</B></FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Departure
                                         of Directors or Certain Officers; Election of Directors; Appointment of Certain Offi
                                         cers; Compensatory Arrangements of Certain Officers.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 1.01 is incorporated into this Item 5.02 by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was no known disagreement with Mr. Harrell with any of our policies, procedures or practices. Mr. Harrell shall remain with us
as a consultant for an additional month following his resignation date of June 30, 2017 as provided above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
an effective date of June 30, 2017, our board of directors has appointed Mr. Gus D. Halas to serve as chairman of the board of
directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8 &ndash; OTHER EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 10%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                                         8.01</B></FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                         Events</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 11, 2017, we issued a press release concerning the Agreement and the appointment of Mr. Halas as chairman. A copy of the press
release is attached as Exhibit 99.1 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 8.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed &ldquo;filed&rdquo; for
purposes of Section 18 of the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange
Act, except as expressly set forth by specific reference in such a filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9 &ndash; <FONT STYLE="text-transform: uppercase">Financial Statements and Exhibits</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 10%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                                         9.01</B></FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                         Statements and Exhibits. </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -72pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 9%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 90%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><A HREF="f8k051117ex10i_optimizerx.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separation and Stock Purchase Agreement, dated May 11, 2017</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><A HREF="f8k051117ex99i_optimizerx.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated May 17, 2017</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx
    Corporation</B></FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Douglas Baker</FONT></TD>
    <TD STYLE="padding: 0 0 1.5pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
        Baker</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
        Financial Officer</FONT></P></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 17, 2017</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>f8k051117ex10i_optimizerx.htm
<DESCRIPTION>SEPARATION AND STOCK PURCHASE AGREEMENT, DATED MAY 11, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 10.1</B></FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separation
and Stock Purchase Agreement dated May 11, 2017 by and between OptimizeRx Corporation, 400 Water St, Suite 200 Rochester, Michigan
48307 (&ldquo;<B>Buyer</B>&rdquo;) and David Harrell (&ldquo;<B>Seller</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
good and valuable consideration, receipt of which is hereby acknowledged, the parties agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
                                         shall sell to Buyer and Buyer shall purchase from Seller five hundred thousand (500,000)
                                         shares of the common stock, $.001 par value, of OptimizeRx Corporation (&ldquo;<B>Shares</B>&rdquo;)
                                         at a price of $0.78 per share for an aggregate price of ($390,000)(&ldquo;<B>Purchase
                                         Price</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         soon as practical following the execution hereof, Seller shall deliver to Buyer one or
                                         more certificates representing the Shares duly endorsed by Seller for transfer to Buyer,
                                         whereupon Buyer shall electronically transfer the Purchase Price to the account specified
                                         by Seller in accordance with the transfer instructions provided by Seller. The purchase
                                         and sale of the Shares shall be deemed consummated for all purposes when Buyer&rsquo;s
                                         electronic transfer of the Purchase Price to Seller is delivered.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
                                         is responsible for and shall timely pay all taxes associated with the sale of the Shares
                                         to Buyer and Buyer has no obligation to pay same or to reimburse Buyer therefor.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
                                         represents and warrants that:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
                                         has, and will transfer to Buyer, good and marketable title to the Shares, free and clear
                                         of all liens, claims and encumbrances;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement has been duly executed and delivered by Seller, and constitutes his valid and
                                         binding agreement enforceable in accordance with its terms;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller&rsquo;s
                                         execution, delivery and performance of this Agreement (a) require no action by or in
                                         respect of, or filing with, or consent of, any governmental body, agency or official
                                         or any other person and (b) do not contravene, or constitute a default under, any provision
                                         of applicable law or regulation or of any agreement, judgment, injunction, order, decree
                                         or any other instrument binding on him;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
                                         is a sophisticated individual familiar with transactions similar to those contemplated
                                         by this agreement, has considerable knowledge and experience in financial and business
                                         matters, and is capable of evaluating the merits and risks of the transaction described
                                         herein;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
                                         has evaluated the merits and risks of selling the Shares on the terms set forth in this
                                         Agreement, and is willing to forego through such sale the potential for future economic
                                         gain (or loss) that might be realized from the Shares;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
                                         (a) has negotiated this agreement on an arms-length basis and has had an opportunity
                                         to consult with legal and financial advisors concerning this agreement and its subject
                                         matter and (b) as a member of Buyer&rsquo;s board of directors, has had access to such
                                         information regarding the business and finances of the Buyer and such other matters with
                                         respect to Buyer as requested and as a reasonable person would consider in evaluating
                                         the transactions contemplated hereby, including, in particular, all information necessary
                                         to determine the fair market value of the Shares and the financial statements of Buyer
                                         for all relevant periods.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
                                         acknowledges that:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
                                         is not acting as a fiduciary or financial or investment adviser to Seller, and has not
                                         given Seller any investment advice, opinion or other information on whether the sale
                                         of the Shares is prudent; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         price for the Shares may significantly appreciate or depreciate over time and by agreeing
                                         to sell the Shares pursuant to this Agreement, Seller is giving up the opportunity to
                                         sell or otherwise realize value from the Shares at a possible higher price in the future.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
                                         represents and warrants that:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement has been duly executed and delivered by Buyer, and constitutes its valid and
                                         binding agreement enforceable in accordance with its terms;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement and the purchase of the Shares have been authorized by the Buyer&rsquo;s board
                                         of Directors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 54pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer&rsquo;s
                                         execution, delivery and performance of this Agreement (a) require no action by or in
                                         respect of, or filing with, or consent of, any governmental body, agency or official
                                         or any other third party and (b) do not contravene, or constitute a default under, any
                                         provision of applicable law or regulation or of any agreement, judgment, injunction,
                                         order, decree or any other instrument binding on it.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Harrell Corporate Consulting Agreement dated May 5, 2016 between Buyer and Seller shall
                                         terminate on July 31, 2017 but otherwise remains in full force and effect until that
                                         date. No compensation shall be due or payable thereafter to Seller under such agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
                                         June 30, 2017, Seller resigns from the Buyer&rsquo;s board of directors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Separation Agreement and Release dated May 5, 2016 between Buyer and Seller remains in
                                         full force and effect.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Consultant Confidentiality, Invention Assignment and Non-Compete Agreement dated May
                                         5, 2016 between Seller and Buyer remains in full force and effect.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         parties&rsquo; obligations under this Agreement, which by their nature are intended to
                                         continue beyond the termination or expiration of this Agreement, will survive the termination
                                         or expiration of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: -18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                         notices and communications hereunder will be deemed given when mailed by certified or
                                         registered mail, postage prepaid to a party at the address set forth above or such other
                                         address as the party may designate in writing to the other from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: -18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         agreement is governed by Michigan law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: -18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         party&rsquo;s failure to insist on performance of any term or condition of this Agreement
                                         or to exercise any right or privilege hereunder will not be construed as a waiver of
                                         such term, condition, right, or privilege in the future</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: -18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         parties may execute this agreement in multiple counterparts, each of which constitutes
                                         an original, and all of which, collectively, constitute only one agreement. The signatures
                                         of all of the parties need not appear on the same counterpart, and delivery of an executed
                                         counterpart signature page by facsimile or other electronic means is as effective as
                                         executing and delivering this Agreement in the presence of the other parties to this
                                         Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: -18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         agreement is entire and complete as to all of its terms and supersedes all previous agreements,
                                         promises, proposals and representations made between the parties, including any oral
                                         or written representations made by any representatives and/or agents of a party or any
                                         marketing materials, advertising or other media. No modification or amendment of this
                                         Agreement will be binding unless agreed to in writing and signed by both parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Witness Whereof, the parties have signed and delivered this agreement as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OptimizeRx
Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt 0pt 1.5pt; text-align: left; width: 4%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 36%; padding-top: 0pt; padding-right: 0pt; border-bottom: Black 1.5pt solid; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt 0pt 1.5pt; text-align: left; width: 60%; text-indent: 0pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: left; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: left; text-indent: 0pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; border-bottom: Black 1.5pt solid; padding-left: 0pt; text-align: left; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; border-bottom: Black 1.5pt solid; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt 0pt 1.5pt; text-align: left; text-indent: 0pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0pt; text-align: left; text-indent: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">David Harrell</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left; text-indent: 0pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>f8k051117ex99i_optimizerx.htm
<DESCRIPTION>PRESS RELEASE, DATED MAY 17, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: normal 10pt Times New Roman, Times, Serif; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>Exhibit
99.1&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: normal 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: center; font: normal 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;<IMG SRC="ex99i.jpg" ALT=""></FONT></P>

<P STYLE="margin: 0; text-align: center; font: normal 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>OptimizeRx
Appoints Gus D. Halas as Chairman of the Board</B></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>Rochester,
MI (May 17, 2017)</B> <FONT STYLE="font-weight: normal">OptimizeRx Corp. (OTCQB: OPRX), the leading aggregator of pharmaceutical-sponsored
services in electronic health record (EHR) platforms, has appointed company director, Gus D. Halas, as chairman of the board,
effective June 30, 2017. He will succeed retiring chairman and company founder, David Harrell.</FONT></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"><FONT STYLE="font-weight: normal">&nbsp;</FONT></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Harrell
is recognized as a leading pharmaceutical industry innovator who pioneered the development of point-of-care marketing. As the
company&rsquo;s CEO until February of last year, Harrell created the first technology and network to automate customized copay
savings and other patient support directly within a physicians&rsquo; existing electronic prescribing workflow.</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Today,
OptimizeRx offers the largest point-of-prescribe promotional network in the industry, reaching more than 500,000 healthcare providers
through more than 370 electronic health record systems (EHRs) nationwide. Through this broad network, OptimizeRx delivers patient
support for 25 of the world&rsquo;s largest pharmaceutical companies.</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">&ldquo;Over
the course of the last year, my primary role as chairman has been to assist in the transition of leadership, including the succession
of William Febbo as CEO and now Gus as our new chairman,&rdquo; said Harrell. &ldquo;Given our strong revenue growth in the first
quarter and the expected further acceleration in the current quarter and beyond, I&rsquo;m confident OptimizeRx is now well positioned
to pursue the billion-dollar market opportunity we created.&rdquo;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">&ldquo;I
also want to express my sincere gratitude to all OptimizeRx&rsquo;s employees, technology and pharmaceutical partners, board members
and shareholders who have worked together to deliver millions of dollars in savings to patients while encouraging greater compliance
with their prescriptions,&rdquo; continued Harrell. &ldquo;I couldn&rsquo;t be more proud of what we&rsquo;ve accomplished or
more optimistic about the future of OptimizeRx.&rdquo;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Febbo
commented: &quot;On behalf of the staff and members of the board, we extend our deepest appreciation for Dave&rsquo;s service
and dedication to OptimizeRx, and especially for his vision of delivering better and more affordable healthcare which has formed
its foundation. Dave's leadership and insights over the last year have been invaluable, creating a smooth transition and helping
us set the right course ahead.&rdquo;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Commented
Halas: &ldquo;Thanks to the leadership of Dave and Will, OptimizeRx is now well established as the leading health technology company
for the pharmaceutical industry at point of care, offering the broadest and deepest reach to healthcare providers. As the company&rsquo;s
new chairman, I will work closely with the board and management in taking OptimizeRx to the next level of growth and development,
with the effort supported by increased investments in sales, products and marketing.&rdquo;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Halas
has served as director of OptimizeRx for nearly three years, and brings to the chair extensive operational experience and accomplishment
across a range of industries. He also currently serves on the boards of Triangle Petroleum, a publicly-held, independent energy
company, and Hooper Holmes, a publicly-held health and wellness company. He is a member of the advisory board of White Deer Energy,
and previously served as CEO of Central Garden and Pet Corp, a leading pet care retailer. He holds a Bachelor of Science in Physics
and a Bachelor of Science in Economics from Virginia Polytechnic Institute and State University.</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">OptimizeRx&rsquo;s
consulting agreement with Harrell, which was previously scheduled to end on September 30, 2017, will now end July 31, 2017. The
company will also acquire 500,000 shares of Harrell&rsquo;s common stock of OptimizeRx at $0.78 per share, after which Harrell
will have approximately 2.1 million shares.</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">&ldquo;We
took this opportunity to reduce our shares outstanding at a fair price, while still maintaining the necessary cash levels to fund
our growth initiatives,&rdquo; noted Febbo. &ldquo;OptimizeRx management and the board believe the company&rsquo;s growth and
strong prospects of both its pharmaceutical products and distribution network are not reflected by the company&rsquo;s current
valuation.&rdquo;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>About
OptimizeRx Corp</B><FONT STYLE="font-weight: normal; font-variant: normal">&nbsp;</FONT></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Based
in Rochester, Michigan, OptimizeRx Corporation is a health technology software company that is revolutionizing the point of care
experience through technology to improve clinical decisions and outcomes. OptimizeRx&rsquo;s unique consumer and physician platforms
help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare
companies effective ways to expand awareness, access and adherence to their medications.</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">The
OptimizeRx core product replaces drug samples with electronic trial vouchers and copay coupon savings that are electronically
added to an e-Prescription and sent electronically to the pharmacy and is integrated within leading electronic health record (EHR)
platforms in the country, including Allscripts, DrFirst, NewCrop, Quest Diagnostics, Practice Fusion and other EHRs to reach over
500,000 healthcare providers. In turn, OptimizeRx promotes patient savings and support from the world&rsquo;s largest pharmaceutical
companies, including Pfizer, Lilly, Novartis, AstraZeneca, and many others. For more information, visit <U>www.optimizerx.com</U>.</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>Important
Cautions Regarding Forward Looking Statements</B></FONT>&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">This
press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended
and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment
decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak
only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking
statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject
to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially
from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>OptimizeRx
Contact:</B></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Doug
Baker, CFO</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">dbaker@optimizerx.com</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Tel
(248) 651-6568 x807</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>Investor
Relations Contact:</B></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Ron
Both</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">CMA</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">oprx@cma.team</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">Tel
(949) 432-7557</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99i.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99i.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  V 10# 2(  A$! Q$!_\0
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M/DG)4XS\;!Y)C,=A:V*H>S:H5O8SISDXSYKP4G=I4XP@I.4YSG%1C";>RO\
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M\*RJC.BR! ZJ[JK!78']QO\ @YH\7_\ !23PYX!^$NG?L46GQMG^".N_"O\
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MQCR2IQ514I2Q4[:I.5^:\K13>EK'ZQT5_G2_\)C_ ,'<'_/C^V=_X1'P<_\
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MU5A&,N6G.JI7D[4:>-FXQDX0A)*235XPK2MJFTFXI.QU?_"KOVDO^A5^*_\
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MYKQEXG?22RGPCX4X.R?A'%X7A7 <#XWCJ?$F>\08[$T95(8VEQEAL#0P.6+
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MJ17[EGX;_#W1+"\GT?P-X1TV>"RNF@N++P[I-O<1,D$A1XYX[19492 597#
M@8/%?AS\.]%L?$OCKP5X>U03/INN^)M"TG4!!*8;AK/4-0M[:Y$,P5C%*8I&
MV2;6V-AMIQBO^=_]I.^/9\8_19^M/A3!<7O/^((Y!5R.MGF*R:AG$N*O#&.4
MU\9+B;!4\0Z-'.IY;5K1EAJU"6$IUO:TZEYTI\&4>RY,;;G=/DAS<W*I./)6
MYDN1VNX\UM;W:]3]!?\ AOSP_P#]$UUO_P *#3__ )!KE_%'[>VHW6G7%MX/
M\!1:3J,L;QPZIKFKKJ4=HSKM$\>FVEE:K-+$26C6:\,!94,L<B;HV]T_X8G^
M"/\ SP\5_P#A12?_ "+7YU_&[X.:Y\%?&+:;<!K[P_?327OA37)84D@U"RBE
M63[%>HRF'^TM/W1P:A:NH2X0I=1H;:Y55\_Z0'&G[2CP6X(?$O'''?#+X5QV
M,CDN:9]X=Y-PICL?PZ\=#V6&Q6/Q%'A?"8S)Z.,G.KA<#FE"G4C3S&-+#2Q.
M Q.(P-6K6%IY1B*G)3ISYTN:,:LJB4[:M).;4FMW%]+NS28_X5_"WQG\>_',
MC2&_N;"[U5M1\;>+[E6:&WCN;C[1J!-RRB&XUB]5Y%LK&(EP[K*Z0V<,DB?K
MQXB^)_PR^&4OASPUKWB/2M#%TT.BZ=;/<Q.NFQVEG_HG]IK&[S:99-%"EO%?
M7D<=H)C''+/'O#5^:WBS]KCQ1J7@70_!G@31+#X>S?8%M_$FH>'8(+-KB\+>
M4T/AFVM8T71[6\4+--*JMJ EF-K;2Q)$;BYY+3?V5_C?X@LM'UR7P\8'\2ZE
M#;JFL7Q35K:WN(9[E]<UZ*199K#3XTA(D-W(=3DFFMXDL7DG0-\AX&^+N&\#
M\IXCX>^BEP)Q=])WQ-XFCP]Q+XI>*68</<0Y?P_@(XC&86OA>&LOR*D\5Q!4
MC#&Y[F>&S#,LZSO"XG%\2X_,LSI+-H9-.O1O$T'B90GC:M/!T8<\*%%3@Y.R
M=YN6D-HQ:C&+2@HKW>;7]HX)X;F&*XMIHKBWGC2:">"1)89HI%#QRQ2QEDDC
M="&1T8JRD,I((-%>&_"?X'6OPT\&6/AF3Q;XLU2YCEDO+RX@UW4]-TZ.[N(X
M4FM])TZVN5CLM-B,(\B%FDD>1IKB1@\QC0K_ &GX:SWCK,^'LDS'B'@##<.Y
M[CLKP6*S?(8\:Y1F2R?,:]"%3%9<L?1R94L4\+4E[-U8<R4N:E*=6="I6K?/
M3C34Y*%7GBI-1E[.<>9)Z.U]+]O\SW>BBBONS,^1?VP_V$OV5/V]/AVOPT_:
MD^$7A_XDZ-8O<7/AO6IOM&C^-?!6HW,)ADU3P7XTT>:R\1^'+MQY;74-C?KI
MNJ"""'6+#4;6,05_,K\3O^#.G]GK6-=NK[X0?MD?&'P#H$TSR6_A_P =?#[P
M?\2[JRB=B5@C\0:3JOPYEF2-2$5KK3)YG W23,V2W]'%O_P46_9PD\03:3>K
M\7=%\/V_Q:U+X'3_ !3UOX(?%#3O@U!\3],\:77PZD\-7'Q4E\-'P;;/=>.;
M5O"]C?W.J0Z;<ZO-:VRW:FYB+?8\OC3P=#K]QX4F\6>&HO%%II3:[=^&Y==T
MN/7[71$R'UFXT=[H:C#I2D'=J$ELMHN#F85]IP[X@\;<(T98;A_B+,<NPDY2
MG]24Z6)P2G)ISJ4\)C:.+H49R=G.5"-!R;YJD9R]X[<)FF/P2:PF,K48MW<(
M3O"^NO))2C=ZZI*_G8_E<_9U_P"#1C]B7X<>(++Q!^T!\:OC'^T?#87$-RO@
MZ"WTGX0>"=2,4BNUKKL/AJZUSQE?64H!22'3?&VB.X.&E,9:,_U"?"CX1_##
MX%?#_P -_"KX-^ O"WPS^'/A"PCTWPWX-\&Z/9Z'H.E6B<MY%E911H]S<2%K
MB^OIS-?:A=R37E]<7%U-+,_A>E_MV?LIZQX3^&_C>Q^,'AI_#7Q6^(^I?"CP
M=J$TDUL9O&NDOXI6]L=9M[B.*X\.6"KX.UJ>'6]>BT_1[FU.EW5O>RV^MZ1)
M>_2H\8>$CX@MO"8\4^'#XJO-,.M6GAD:WIA\076C@D'5K;1A=?VC/I@((-_%
M;-:@@CS<UR<2<:<6<6SIRXDSW,<UC1DY4*&(J*GA*$VN64Z6"P]/#82%2SY7
M4]A.KRMQ]K&+<7.*S#&8YJ6*Q57$./PJ<[QC>_PP5H*_=1O;2]M#\7O^#CO_
M )0Z?M;?]<?A)_ZNOX>5_,S_ ,&QG['7[/7[=/P4_P""DOP$_:5\ 6/CSP%J
MUY^R_J=@QD?3O$OA#Q):VWQ[AT_Q9X(\2V@75/#/B.P6>1([ZPF6&]M7FTS5
M[74M)N;NPG_M9_;/_9D^#_\ P42_9E^)W[*'B_XC:EI7A'XCVWA6XU_6_A?K
MGA>Z\6Z5:^'O&MAXBTVYLFU.P\1:9#!>ZUX1GTN6:]TJXCE6VU.V@9+NV=X/
MR*_X)E_L^_L#_P#!)?QQ^T!X,^ 'Q _:Y^.>G?$[QW\.OAK\4?B=JGP@UOXA
M?!_X=>/_  #J'BG1=/\ "C_$7X7_  OT?08-2BU?QW/I?BR59=>L- U!+.TU
M2]T>:VU!%_1.&./LKR/PDXFX7HX[,<%Q7C>(<'FV43P>'Q,(THX;$9+55=9E
M2JTX8:M!8'$N,7%RE90M*-5PEZN$S3#X;(\;@O:5(8RMB:=:@X1ERKDEAY<W
MM8R7))>SDUIVUU/A#Q#_ ,&<'P+NO%<UYX5_;;^+FB>"I+MY(] USX5>"_$G
MB:VLFD9DM%\66>O^&]-GF2(K$+V7P@ 64RM:OD1C]]/^"<O_  2(_8X_X)D:
M%J@^ WA35O$'Q-\3V$6F^,_C?\2+VT\0?$OQ!IR/%.=#M+VTL-,T?PIX7^V1
M)='P]X5TG2K:]GAM+C7)=9O;*UO(OT?_ .$O\)CQ*/!A\4>'1XP-C_:@\*?V
MWIO_  DITP==1&A?:?[4-B/^?O[+]G_Z:55L?'O@;4]3?1--\9^$]0UF.QNM
M4?2+'Q%H]WJ::98WDNG7NHO807DETMC9ZA;SV-U=F(6]O>0RVTLB3QNB_&Y[
MXF\>\2Y?_96=\3YEC<N?+[7"_P"SX:GB5!IP^M_4\+A9XM*45+EQ$YTW-*<J
M4Y*+CY^(S;,<735'$XVO5I7UA*=HR:_F45'G>OVN;I=.RMU,D<<T<D,T:2Q2
MH\<L4B*\<D;J5>.1&!5T=25=&!5E)!!!(K^3S]J#_@TG_9#^,GQ3\2?$;X)?
M';XE?LVZ/XLU>^UW4OAG8>%/#_Q&\$Z+J&IW<MY?0>"5U/4_#>M^'=%::9WL
M]$O-6UVTTP,;73C:Z=';65M_5!HOC3P=XEO+O3O#GBSPSK^H6%I8W]]8Z+KV
MEZK>65CJ<?G:;>7=K8W4\]M::A%^]L;B9$ANX_G@>1>:31O&_@SQ'IVIZQX>
M\7>&->TC1;F]L]9U71M?TK5-.TF[TQ/,U&UU.^L;N>VL+G3X_GO8+J6*6T3Y
MIUC7FO)X:XPXFX/Q%?%<-9QB\IJXJG"EBE0]E.CB(0DY4U7P^(HXC#U'2E*3
MI3E252FY34*BC.4)8X3'8O SE4PF(J4)37+)TY64DG>TD[QE9ZJZT[J^OYA?
M\$IO^"1?P8_X)0^"OB=X>^&/Q'^(_P 4?$?QBU+PMJ?CSQ/X\_L&PLW?P;;:
MW:Z%;>&_#>@:=;0:):QQ^(=3:]-WJ6M7=Y(\!:[CBMXXA\6?&O\ X-O/V>?C
M=^W3KW[=VM?M#_&O1O'&O?'+PE\<YO!.E:7X$?PG!K7A'5?#NJVFAPW%YHLV
ML'2KJ3P[;Q7$KW9NU2XF:.165"/V[\5_M1? #P7<_"R#7OBKX.B@^-'BG5?!
MOP[U:RUJQU30-<U[1- U?Q)JD#Z_ITUSI&G6MGIVB7L<NHZC>6M@-4>PT;[1
M_:NJ:=9W/4Z)\8?!NI:-XV\1:S<3> ]"\!>./$/@/6]7^($VD^&-,DO_  [=
MV]E+J]EJ%SJDMFWA_4YKJ$Z-?7D]E<7J,"]E S(K=='CWC+#YOFN?T<^QT,X
MSS#2P6:X_EPSK8W"2C&D\/44\'*E&DH0C3C&C1I.,8QBI*UW4<QQD:];$+%5
M/;UX2IUJKDG.I"44I1DW%Z.*2>BT6Y\B_P#!33_@G9\/_P#@IU^SKIO[.7Q)
M^('C/X;>'M-^)OA?XG1^(? MMH=WK4NI>%M*\2Z3;:9)%X@LK^Q^P74/B:YE
MG=81<++;6_ER!#(K\W_P2Y_X)D?#C_@EE\&/'?P5^&7Q*\=?$[1?'?Q-N_B=
M>:OX^L_#UGJFGZC>>&/#?AB33+1/#ECI]H]@MOX;M[I'GB>X\^YG4R&)8U7]
M!-6\?>!- L+;5==\:^$M%TN]TUM9L]2U;Q'H^FV%WHZ&S#ZK;7EY>0V\^FH=
M0L U]%(]JIOK,&4?:8=[]1\=^"-(O/#VGZMXR\*Z7?\ BXX\)V.H^(=(LKSQ
M.=D4N/#UM<WD4VM'RIX9,::ER=DT3_=D0GS5Q-GT>'Y<*K,L0N'IXW^T995R
MT?J\L:IJK]8YOJ_M^=3BI66(4+KX+71G];Q"PSP?MI?5G455T;QY'43NI[7O
M?;4^8OV^OV-?"/[?W[*WQ)_93\=>,?$W@+PO\2Y/"<FI>*?"%OI5SX@T[_A$
M_&&A>,+9;&'6[:\TUA>7>A06=R9[>0K:SS&+9,$=?D__ ()3_P#!(#X3_P#!
M*"Q^-EA\+?BU\1_BE%\;KWP-?:RWQ!L?"]FVBR>!;;Q-;62Z5_PC>FZ>)%OU
M\37#7?VP2E3:V_D[ 9=_ZI^,O%FB> O"'BKQUXEN)+/PYX+\-ZYXL\07<-O-
M=S6NB>'-+NM8U6XBM+9)+BZD@L+.>5+>"-YIF41Q(SLJGY:^$'[=GP*^,_B[
MP)X)T.U^+/A#7?BKX8U#QC\*?^%J_!?XE_##2OB=H&DZ3::_J=WX"UWQCX<T
MO1O$LMCX?OK77Y[.POI+PZ+*=3B@ELXII8S#\2Y_A\@QG#&'S+$4^'\?BH8W
M&Y9&-!X>OBJ;H2A6G*5"5=3B\-0:Y,1"/[M7A9RYE'%UX8>>$C6E'#U9JI.C
MIR3FK)2?NWNK)+WEML>J?M/? C1/VH?V=_C5^SIXDUW5_#'A_P"-GPV\6?#3
M6?$6@1V4VMZ+IWBW2+G2+O4M*BU&&XL)+^TAN6FMEO()K<RJOFQNF5/Y;?\
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M\-;"+F]R,8_[1]9O9;O5Z?7L5;#+V\[8.[PJO']Q=\SY--+O5WOKKH?R0?\
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M:G\,+K4]06S^$*:!I6NP^,KKPSKEQH(T?5=*U&P\&Z/JLNNPZY';V]DWQ_\
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3[UMHK+?8HHHK^@SE"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
